Biblio

Export 3288 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
D. Arnaldi, Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S., Famá, F., Terzaghi, M., Girtler, N., Brugnolo, A., Doglione, E., Pardini, M., Villani, F., and Nobili, F., “Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”, J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., “Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
I. A. C. Arnoldussen, Sundh, V., Bäckman, K., Kern, S., Östling, S., Blennow, K., Zetterberg, H., Skoog, I., Kiliaan, A. J., and Gustafson, D. R., “A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
B. Arosio, Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E., Rossi, P. Dionigi, and Mari, D., “Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.”, J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.
I. Arrieta-Cruz, Knight, C. M., and Gutiérrez-Juérez, R., “Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism.”, J Alzheimers Dis, 2015.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
E. Ma Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., “Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1437-1443, 2017.
S. Egebäck Arulf, Zhou, R. Ziyue, Kirsebom, B. - E., Jejcic, A., Fladby, T., Winblad, B., Tjernberg, L., and Schedin-Weiss, S., “Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases.”, J Alzheimers Dis, vol. 100, no. s1, pp. S93-S101, 2024.
D. Asaoka, Xiao, J., Takeda, T., Yanagisawa, N., Yamazaki, T., Matsubara, Y., Sugiyama, H., Endo, N., Higa, M., Kasanuki, K., Ichimiya, Y., Koido, S., Ohno, K., Bernier, F., Katsumata, N., Nagahara, A., Arai, H., Ohkusa, T., and Sato, N., “Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 88, no. 1, pp. 75-95, 2022.
D. Aschwanden, Sutin, A. R., Ledermann, T., Luchetti, M., Stephan, Y., Sesker, A. A., Zhu, X., and Terracciano, A., “Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., “Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.
P. R. Asih, Tegg, M. L., Sohrabi, H., Carruthers, M., Gandy, S. E., Saad, F., Verdile, G., Ittner, L. M., and Martins, R. N., “Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.”, J Alzheimers Dis, vol. 59, no. 2, pp. 445-466, 2017.
E. Aso, Andrés-Benito, P., and Ferrer, I., “Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.”, J Alzheimers Dis, vol. 54, no. 3, pp. 903-912, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., “Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.”, J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., “Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
B. Atanasova, Mondon, K., Dreyfuss, L., Beaufils, E., Desmidt, T., Hommet, C., El-Hage, W., and Belzung, C., “Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals.”, J Alzheimers Dis, vol. 61, no. 3, pp. 929-938, 2018.
M. Atee, Hoti, K., Parsons, R., and Hughes, J. D., “Pain Assessment in Dementia: Evaluation of a Point-of-Care Technological Solution.”, J Alzheimers Dis, vol. 60, no. 1, pp. 137-150, 2017.
R. Zayed Atef, Michalowsky, B., Raedke, A., Platen, M., Mohr, W., Mühlichen, F., Thyrian, J. René, and Hoffmann, W., “Impact of Hearing Aids on Progression of Cognitive Decline, Depression, and Quality of Life Among People with Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 92, no. 2, pp. 629-638, 2023.
K. J. Atkins, Scott, D., Silbert, B., Pike, K. E., and Evered, L., “Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.
J. L. Atkins, Pilling, L. C., Heales, C. J., Savage, S., Kuo, C. - L., Kuchel, G. A., Steffens, D. C., and Melzer, D., “Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1203-1211, 2021.
C. S. Atwood and Perry, G., “Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?”, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
E. Audronyte, Pakulaite-Kazliene, G., Sutnikiene, V., and Kaubrys, G., “Odor Discrimination as a Marker of Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1169-1178, 2023.
J. Avila, “Our Working Point of View of Tau Protein.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1277-1285, 2018.
Á
M. Ávila-Villanueva, Maestú, F., and Fernández-Blázquez, M. A., “Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories.”, J Alzheimers Dis, vol. 66, no. 1, pp. 173-183, 2018.

Pages